Inborn errors of metabolism Flashcards

1
Q

Inborn errors of metabolism

A

Single gene defects resulting in disruption to metabolic pathways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Consequence of IEM

A
  • Toxic accumulation of substrates
  • Toxic accumulation of intermediates from alternative metabolic pathways
  • Defects in energy production/use due to deficiency of products
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Alkaptonuria

A

Deficiency in homogentisic acid oxidase:
· Autosomal recessive disorder
· Urine turns black on standing (and alkalinisation)
· Black ochrontic pigmentation of cartilage & collagenous tissue (ochronosis)
· Congenital

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cystinuria

A

Mutations of SLC3A1 amino acid transporter gene (chromosome 2p) & SLC7A9 (Chromosome 19), causing defective transport of cysteine and other dibasic amino acids through epithelial cells of renal tubule and intestinal tract

· Autosomal recessive disorder
· Cysteine has low solubility in urine→formation of calculi in renal tract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Mechanisms of Inheritance

A
Autosomal Recessive
Autosomal Dominant
X-linked
Co-dominant
Mitochondrial
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Autosomal recessive inheritance

A
  • Both parents carry a mutation affecting the same gene
  • 1 in 4 risk each pregnancy
  • Consanguinity increases risk of autosomal recessive conditions
  • Examples: cystic fibrosis, sickle cell disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Autosomal dominant inheritance

A
  • Rare in IEMs

- Examples: Huntington disease, Marfan’s, Familial hypercholesterolemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

X-linked inheritance

A

Recessive X linked conditions are passed through the maternal line

  • Condition does appear in males
  • Condition carried in females, but not usually expressed (because females have two copies of X chromosome). Female carriers may manifest condition→Lyonisation (random inactivation of one of the X chromosomes)
  • Example: Haemophilia A, Duchenne, Muscular Dystrophy, Fabry’s Disease, Ornithine Carbomyl Transferase Deficiency

Dominant X linked conditions are passed on from either affected parent
-Affected father will only pass the condition to his daughters
-Affected mother can pass the condition to sons and daughters
-Example: Fragile X
There is no male to male transmission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Co-dominant inheritance

A

· Two different alleles of a gene are expressed, and each allele makes a slightly different protein. Both alleles influence the genetic trait or determine the characteristics of the genetic condition
Example: ABO blood group, ⍺1AT deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Mitochondrial inheritance

A

· Mitochondrial gene mutation
· Inherited exclusively from mother:
-Only the egg contributes mitochondria to the developing embryo

· Affects both male and female offspring
· E.g. MERRF- Myoclonic epilepsy and ragged red fibre disease: deafness, dementia, seizures
· E.g. MELAS- Mitochondrial encephalopathy with lactic acidosis and stroke-like episodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is heteroplasmy?

A

presence of both normal and mutated mtDNA resulting in mitochondrial inherited disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How does heteroplasmy arise?

A

When the mitochondria replicates, it is separate from the nucleus replicating. The mitochondria RANDOMLY segregates in the cells, and sometimes they will segregate with all wildtype, sometimes they will have a combination of wildtype and mutant, and sometimes they will contain all mutant mitochondria.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What does level of heteroplasmy determine?

A

· Distribution of the affected mitochondria, and thus level of heteroplasmy, determines presentation.

· Mitochondrial disease can vary in symptoms, severity, and age of onset.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which organs are more commonly affected in mitochondrial diseases?

A

· High energy-requiring organs (e.g. brain, liver, kidneys) which are more frequently affected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Prevalence of inborn errors of metabolism

A

Individually rare

Collectively common
- cumulative frequency accounting for high mortality within the first year of life

significant contribution to the 1% of children of school age with physical handicap and the 0.3% with severe learning difficulties

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What does presentation of IEM depend on?

A

Depends on:

  • where the gene is and what the specific enzyme is
  • age
17
Q

Presentation of neonates with IEM

A
  • neonatal presentation often acute
  • often caused by defects in energy metabolism
    >maple syrup urine disease
    >tyrosinaemia
    >OTC (urea cycle defect)
18
Q

Clues for IEMs in neonates

A
  • Consanguinity
  • Family history of similar illness in siblings or unexplained deaths
  • Infant who was well at birth but starts to deteriorate for no obvious reason (acute symptoms arising)
  • symptoms present in the first week of life, when starting full milk feeds
19
Q

Describe late-onset of IEM

A
  • Late onset due to accumulation of toxic molecules
  • Symptoms appear at adulthood
  • Present with organ failure, encepalopathy, seizures
  • Patients have residual enzyme activity allowing slower accumulation of toxins
20
Q

IEMs in adults

A
  • Wilson’s

- Haemochromatosis

21
Q

Treatment for IEM

A
  • dietary control/restrictions
  • compound supplementation
  • Newer drug and enzyme replacement therapy
  • organ transplantation
22
Q

Classification of IEM

A

Toxic accumulation:
> Protein metabolism disorder
> Carbohydrate intolerance (galactosaemia)

Deficiency in energy production/utilization:
> Fatty acid oxidation disorder
> Mitochondrial disorder
> Carbohydrate utilization/production disorder

Disorders of complex molecules involving organelles:
> lysosomal storage disorders (Fabry’s)
> Peroxisomal disorders (Zellwegers)

23
Q

Symptoms of IEMs

A

Non-specific:
-poor feeding, lethargy, vomiting, hypotonia, fits

Specific:

  • abnormal smell (sweet, musty, cabbage-like)
  • cataracts
  • hyperventilation 2º to metabolic acidosis
  • hyponatraemia and ambiguous genitalia
  • neurological dysfunction with respiratory alkalosis
24
Q

Biochemical abnormalities in IEMs

A
  • hypoglycaemia
  • hyperammonaemia
  • unexplained metabolic acidosis/ketoacidosis
  • lactic acidosis
25
Q

Clinical presentation of IEMs

A
  • Cognitive decline
  • Epileptic encephalopathy
  • Floppy baby
  • Exercise intolerant
  • Cardiomyopathy
  • Dysmorphic features
  • Sudden unexpected death in infancy (SUDI)
  • Foetal hydrops
26
Q

How do we diagnose IEMs?

A

By laboratory investigations:

  • routine tests
  • specialist tests
  • confirmatory tests
27
Q

Routine laboratory investigations for IEMs

A
  • Blood gas analysis
  • Blood glucose
  • Plasma ammonia
28
Q

Specialist investigations for IEMs

A
  • Plasma amino acids
  • Urinary organic acids + orotic acid
  • Blood acyl carnitines
  • Blood lactate and pyruvate
  • Urinary glycosaminoglycans
  • Plasma very long chain fatty acids
29
Q

Confirmatory investigations for IEMs

A

· Enzymology
>red cell galactose-1-phosphate uridyl transferase
>lysosomal enzyme screening

· Biopsy (muscle, liver)
· Fibroblast studies
· Mutation analysis- whole genome sequencing

30
Q

Neonatal Screening: importance

A

Via new-born screening programmes:

  • early identification of life-threatening disease in pre-symptomatic stage
  • early initiation of medical treatment
  • reduction of morbidity and mortality
31
Q

Criteria for neonatal screening

A

· Condition should be an important health problem

· Must know incidence/prevalence in screening population

· Natural history of the condition should be understood
-there should be a recognisable latent or early symptomatic stage

· Availability of a screening test that is easy to perform and interpret
-acceptable, accurate, reliable, sensitive and specific

· Availability of an accepted treatment for the condition
-more effective if treated earlier

· Diagnosis and treatment of the condition should be cost-effective

32
Q

Criteria for a good screening test

A

· Accurate and reproducible
· Cheap and produces rapid result
· Ethical
· Good statistical performance
-how well the diagnosis influences the test result (sensitivity and specificity)
-how well the test result predicts the diagnosis (positive and negative predictive values)

33
Q

Newborn Blood Spot Screening

A

Taking blood spots for screening:
· Samples should be taken on day 5 (day of birth is day 0)
· All four circles on card need to be completely filled with a single drop of blood which soaks through to the back of the Guthrie card